Evidence map›Paper›PMID 33924363›Full record

ArticleCancers2021

CT Simplified Radiomic Approach to Assess the Metastatic Ductal Adenocarcinoma of the Pancreas.

Mirko D'Onofrio, Riccardo De Robertis, Gregorio Aluffi, Camilla Cadore, Alessandro Beleù, Nicolò Cardobi, Giuseppe Malleo, Erminia Manfrin, Claudio Bassi

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Radiomics in differential diagnosis of pancreatic tumors.European journal of radiology open · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mirko D'OnofrioDepartment of Radiology, G.B. Rossi Hospital, University of Verona, 37129 Verona, Italy.ORCID 0000-0003-3229-9329
Riccardo De RobertisDepartment of Radiology, Ospedale Civile Maggiore, Azienda Ospedaliera Universitaria Integrata Verona, 37126 Verona, Italy.ORCID 0000-0003-0930-4337
Gregorio AluffiDepartment of Radiology, G.B. Rossi Hospital, University of Verona, 37129 Verona, Italy.
Camilla CadoreDepartment of Radiology, G.B. Rossi Hospital, University of Verona, 37129 Verona, Italy.
Alessandro BeleùDepartment of Radiology, G.B. Rossi Hospital, University of Verona, 37129 Verona, Italy.
Nicolò CardobiDepartment of Radiology, Ospedale Civile Maggiore, Azienda Ospedaliera Universitaria Integrata Verona, 37126 Verona, Italy.
Giuseppe MalleoUnit of General and Pancreatic Surgery, The Pancreas Institute, Policlinico GB Rossi, University of Verona, 37129 Verona, Italy.ORCID 0000-0001-5467-2628
Erminia ManfrinDepartment of Pathology, G.B. Rossi Hospital, University of Verona, 37129 Verona, Italy.
Claudio BassiUnit of General and Pancreatic Surgery, The Pancreas Institute, Policlinico GB Rossi, University of Verona, 37129 Verona, Italy.
University of Verona · ITAzienda Ospedaliera Universitaria Integrata Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to perform a simplified radiomic analysis of pancreatic ductal adenocarcinoma based on qualitative and quantitative tumor features and to compare the results between metastatic and non-metastatic patients. A search of our radiological, surgical, and pathological databases identified 1218 patients with a newly diagnosed pancreatic ductal adenocarcinoma who were referred to our Institution between January 2014 and December 2018. Computed Tomography (CT) examinations were reviewed analyzing qualitative and quantitative features. Two hundred eighty-eight patients fulfilled the inclusion criteria and were included in this study. Overall, metastases were present at diagnosis in 86/288 patients, while no metastases were identified in 202/288 patients. Ill-defined margins and a hypodense appearance on portal-phase images were significantly more common among patients with metastases compared to non-metastatic patients (

Indexed as

CTmetastasispancreatic adenocarcinomapancreatic cancerradiomics

Identifiers

PMID33924363
PMCPMC8069159
OpenAlexW3156887371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.